SER Serina Therapeutics Inc.

2,612
Loading...
Loading...
News
all
press releases
News Placeholder
Why Did Serina Therapeutics Stock Rocket 37% After The Bell Today?
The FDA backed advancing its Parkinson’s drug candidate SER-252 into a registrational clinical program, a move that retail traders said could fuel further gains.
Stocktwits·1mo ago
News Placeholder
Serina Therapeutics Stock Soars Pre-Market On $10M Equity Deal To Fund Parkinson’s Trials: Retail Sentiment Explodes
The financing is structured in two tranches, with the first $5 million tranche already received on Nov. 27, and the second tranche due by Jan. 31, 2025.
Stocktwits·10mo ago

Latest SER News

View

Advertisement|Remove ads.

Advertisement|Remove ads.